Holen Sie sich die Stockscreener-App
11.22
1.15%
-0.13
Handel nachbörslich:
11.33
0.11
+0.98%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$11.35
Offen:
$11.42
24-Stunden-Volumen:
2.28M
Relative Volume:
0.70
Marktkapitalisierung:
$1.55B
Einnahmen:
$4.18B
Nettoeinkommen (Verlust:
$-1.79B
KGV:
-0.8562
EPS:
-13.1048
Netto-Cashflow:
$107.70M
1W Leistung:
+5.75%
1M Leistung:
-5.08%
6M Leistung:
-11.23%
1J Leistung:
-57.50%
1-Tages-Spanne:
$11.11
$11.56
1-Wochen-Bereich:
$10.53
$11.56
52-Wochen-Spanne:
$9.225
$28.43
Perrigo Company Plc Stock (PRGO) Company Profile
Firmenname
Perrigo Company Plc
Sektor
Telefon
269-673-8451
Adresse
THE SHARP BUILDING, DUBLIN 2
Compare PRGO vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRGO
Perrigo Company Plc
|
11.22 | 1.57B | 4.18B | -1.79B | 107.70M | -13.10 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-01-14 | Herabstufung | Argus | Buy → Hold |
| 2025-01-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-09-24 | Fortgesetzt | Jefferies | Hold |
| 2023-11-17 | Eingeleitet | Piper Sandler | Overweight |
| 2023-03-07 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-09-14 | Hochstufung | Argus | Hold → Buy |
| 2022-09-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-10-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2021-09-30 | Hochstufung | Jefferies | Hold → Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2021-01-06 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-04-17 | Herabstufung | Argus | Buy → Hold |
| 2020-03-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-20 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-18 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-10-11 | Hochstufung | Argus | Hold → Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2018-11-13 | Herabstufung | Berenberg | Buy → Hold |
| 2018-08-10 | Bestätigt | Stifel | Hold |
| 2018-07-30 | Herabstufung | Argus | Buy → Hold |
| 2018-07-12 | Herabstufung | Goldman | Neutral → Sell |
| 2018-01-03 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2017-12-08 | Hochstufung | Argus | Hold → Buy |
| 2017-11-10 | Hochstufung | RBC Capital Mkts | Underperform → Sector Perform |
| 2017-10-05 | Bestätigt | UBS | Buy |
| 2017-09-07 | Eingeleitet | Oppenheimer | Outperform |
| 2017-08-11 | Hochstufung | Goldman | Sell → Neutral |
| 2017-08-11 | Bestätigt | RBC Capital Mkts | Underperform |
| 2017-06-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-06-05 | Herabstufung | RBC Capital Mkts | Sector Perform → Underperform |
| 2017-03-03 | Bestätigt | B. Riley & Co. | Neutral |
Alle ansehen
Perrigo Company Plc Aktie (PRGO) Neueste Nachrichten
Perrigo Q1 earnings surpass estimates, sales miss, both fall Y/Y - MSN
Compeed Blister Plasters for Active Feet Explained - AD HOC NEWS
Perrigo Co. PLC stock underperforms Friday when compared to competitors - MarketWatch
[Form 4] PERRIGO Co plc Insider Trading Activity - Stock Titan
Perrigo (NYSE: PRGO) CEO receives 173,837 RSUs in new equity grant - Stock Titan
Perrigo (PRGO) CFO awarded 52,678 RSUs, now holds 77,760 ordinary shares - Stock Titan
Perrigo (NYSE: PRGO) awards 31,607 RSUs to EVP and CSO - Stock Titan
Perrigo (NYSE: PRGO) awards 42,142 RSUs to EVP Roberto Khoury - Stock Titan
Perrigo (PRGO) EVP & CBDO David Ball awarded 26,339 RSUs - Stock Titan
Perrigo (NYSE: PRGO) EVP & CHRO receives 22,388 RSU award - Stock Titan
Perrigo (NYSE: PRGO) awards EVP 22,388 restricted stock units - Stock Titan
Perrigo (PRGO) EVP and General Counsel receives grant of 46,093 RSUs - Stock Titan
Perrigo (NYSE: PRGO) director gains shares through RSU grant and vesting - Stock Titan
Perrigo (NYSE: PRGO) director granted 16,681 RSUs and exercises 7,305 units - Stock Titan
Perrigo (PRGO) director logs RSU grant, vesting and tax share disposition - Stock Titan
Perrigo (PRGO) director reports RSU grant, exercise and tax-withholding share disposition - Stock Titan
Perrigo (PRGO) director Orlando Ashford exercises 10,669 RSUs and withholds 5,122 shares for taxes - Stock Titan
Perrigo (PRGO) director reports RSU grant, share conversion and tax withholding - Stock Titan
Perrigo (NYSE: PRGO) director logs RSU grant, vesting and tax share disposition - Stock Titan
Perrigo (NYSE: PRGO) director amends Form 4 for RSU tax withholding - Stock Titan
Perrigo reaffirms 2026 outlook, targets $60M-$80M cost savings as results shift to 2H - MSN
Compeed Blasenpflaster: Advanced Blister Protection for Active Lifestyles - AD HOC NEWS
Perrigo Co. PLC stock underperforms Wednesday when compared to competitors - MarketWatch
Perrigo to Buy Elan for $8.6 Billion - AOL.com
Perrigo Co. PLC stock underperforms Monday when compared to competitors - MarketWatch
Responsive Playbooks and the PRGO Inflection - Stock Traders Daily
Vanguard Group Inc. Buys 1,101,154 Shares of Perrigo Company plc $PRGO - MarketBeat
Perrigo Company plc (NYSE:PRGO) Q1 2026 Earnings Call Transcript - Insider Monkey
Perrigo Shareholders Endorse Directors, Pay and Capital Flexibility - TipRanks
Perrigo Co. PLC stock underperforms Thursday when compared to competitors - MarketWatch
Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y - The Globe and Mail
Perrigo (PRGO) Q1 2026 Earnings Transcript - AOL.com
T. Rowe Price holds 14.0M Perrigo shares (PRGO) in Schedule 13G/A - Stock Titan
T. Rowe Price (PRGO) discloses 13.38M shares; Mid‑Cap Value Fund holds 7.50M - Stock Titan
Assessing Perrigo (PRGO) Valuation After Weak Q1 Results And Lowered Guidance - Yahoo Finance
Jefferies lowers Perrigo stock price target to $14 on weak quarter By Investing.com - Investing.com Australia
Perrigo Company plc Q1 2026 Earnings Call Summary - Yahoo Finance
Perrigo Q1 2026 slides: EPS beats amid market softness, shares gain - Investing.com Australia
Silicone Scar Treatment Products Market 2026- 2033 Overview: - openPR.com
Jefferies lowers Perrigo stock price target to $14 on weak quarter - Investing.com Nigeria
MSN Money - MSN
Perrigo Q1 2026 Earnings Call Transcript - MarketBeat
Perrigo Earnings: While 2026 Expectations Are Low, Recovery Is Playing Out as Expected - Morningstar
Perrigo Co. PLC stock outperforms competitors on strong trading day - MarketWatch
Goodwill impairments drive Perrigo (NYSE: PRGO) to deep quarterly loss - Stock Titan
Perrigo Company Releases Q1 2026 Financial Results - AlphaStreet
Perrigo Company plc 2026 Q1ResultsEarnings Call Presentation (NYSE:PRGO) 2026-05-06 - Seeking Alpha
Perrigo to lay off 161 as company heads toward Vermont site closure - VTDigger
Earnings call transcript: Perrigo Q1 2026 beats EPS estimates, stock rises - Investing.com Australia
Perrigo Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Perrigo Fiscal Q1 Adjusted Earnings, Net Sales Decline - marketscreener.com
Finanzdaten der Perrigo Company Plc-Aktie (PRGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.92%
4.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):